Clinical Report: The ETV4 Transcription Factor's Emerging Significance in Colorectal Cancer
Overview
ETV4 is frequently overexpressed in colorectal cancer (CRC) and is associated with advanced disease and poor prognosis. It regulates key oncogenic processes such as tumor cell proliferation, invasion, and immune evasion.
Background
Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide, with significant challenges in treatment resistance and metastasis. Understanding the molecular mechanisms driving CRC is crucial for identifying new therapeutic targets.
Data Highlights
No numerical data available in the source material.
Key Findings
ETV4 is overexpressed in CRC, correlating with advanced disease and poor prognosis.
ETV4 regulates tumor characteristics including proliferation, invasion, and metabolic reprogramming.
Activation of ETV4 is linked to oncogenic signaling pathways such as MAPK and PI3K/Akt.
ETV4 promotes epithelial-mesenchymal transition (EMT) and chemoresistance in CRC.
It serves as a biomarker for CRC diagnosis and prognosis.
Clinical Implications
The overexpression of ETV4 in CRC suggests its association with disease progression and prognosis.
Conclusion
ETV4 plays a role in the progression of colorectal cancer.
